blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4302089

EP4302089 - SYSTEM AND METHOD FOR CONDUCTING A MULTIPLEXED ASSAY [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.12.2023
Database last updated on 11.09.2024
FormerThe international publication has been made
Status updated on  09.09.2022
Formerunknown
Status updated on  30.03.2022
Most recent event   Tooltip03.05.2024Change: Validation statespublished on 05.06.2024  [2024/23]
03.05.2024Change - extension statespublished on 05.06.2024  [2024/23]
Applicant(s)For all designated states
Meso Scale Technologies, LLC
1601 Research Boulevard
Rockville, MD 20850 / US
[2024/02]
Inventor(s)01 / TSIONSKY, Michael
Derwood, Maryland 20855 / US
02 / KENTEN, John
Terrace Boyds, Maryland 20841 / US
 [2024/02]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2024/02]
Application number, filing date22711386.728.02.2022
[2024/02]
WO2022US18139
Priority number, dateUS202163155008P01.03.2021         Original published format: US 202163155008 P
[2024/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022187138
Date:09.09.2022
Language:EN
[2022/36]
Type: A1 Application with search report 
No.:EP4302089
Date:10.01.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 09.09.2022 takes the place of the publication of the European patent application.
[2024/02]
Search report(s)International search report - published on:EP09.09.2022
ClassificationIPC:G01N33/543, C12Q1/6813, C12Q1/6844
[2024/02]
CPC:
G01N33/54306 (EP,US); C12Q1/6804 (EP); G01N33/582 (US);
G01N2458/10 (EP,US); G01N2458/30 (US); G01N2474/00 (EP,US)
C-Set:
C12Q1/6804, C12Q2531/125, C12Q2537/125 (EP);
C12Q1/6804, C12Q2537/125 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/02]
TitleGerman:SYSTEM UND VERFAHREN ZUR DURCHFÜHRUNG EINES MULTIPLEX-TESTS[2024/02]
English:SYSTEM AND METHOD FOR CONDUCTING A MULTIPLEXED ASSAY[2024/02]
French:SYSTÈME ET PROCÉDÉ DE RÉALISATION D'UN DOSAGE MULTIPLEXÉ[2024/02]
Entry into regional phase01.09.2023National basic fee paid 
01.09.2023Designation fee(s) paid 
01.09.2023Examination fee paid 
Examination procedure01.09.2023Examination requested  [2024/02]
01.09.2023Date on which the examining division has become responsible
16.04.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
01.09.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[I]WO2018111782  (CEPHEID [US]) [I] 1-123 * the whole document *;
 [X]EP3425063  (HARVARD COLLEGE [US]) [X] 1-123 * [0038]; [0182]; [0215] et seq.; [0212] et seq.; [0150] et seq.; [0168] et seq.; [0183] et seq.; [0264] et seq. *;
 [I]WO2020243579  (10X GENOMICS INC [US]) [I] 1-123* the whole document *
by applicantUS5240863
 US5846485
 US2004191784
 US6977722
 US2009163378
 US7842246
 WO2015175856
 US2016069872
 US2017343466
    - BJOERN et al., "Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma", Oncotarget, (20170000), vol. 8, no. 16, pages 27062 - 27074
 WO1997IB19193
 WO2015US30925
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.